SCHEMBL7114636

SCHEMBL7114636

CCCCOC(=O)c1ccc(NC(=O)c2c(O)c(Cl)cc(Cl)c2O)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.69
▸ MEN1 O00255 3/20 0.67
▸ KMT2A Q03164 3/20 0.67
▸ HPGD P15428 2/20 0.61
▸ RECQL P46063 1/20 0.61
▸ ESR1 P03372 2/20 0.60
▸ KDM4E B2RXH2 1/20 0.60
▸ ALDH1A1 P00352 5/20 0.58
▸ MAPT P10636 6/20 0.57
▸ RAB9A P51151 3/20 0.57
▸ HTT P42858 2/20 0.56
▸ MAPK1 P28482 2/20 0.56
▸ GAA P10253 2/20 0.54
▸ TSHR P16473 2/20 0.53
▸ CYP1A2 P05177 2/20 0.53
▸ CYP2C19 P33261 2/20 0.53
▸ LMNA P02545 1/20 0.53
▸ CYP2D6 P10635 1/20 0.53
▸ NR1H2 P55055 1/20 0.53
▸ RNASEL Q05823 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7763476 0.96 SMN1; SMN2 (0.64) SMN1; SMN2MEN1KMT2AHPGDRECQL
SCHEMBL7119082 0.88 RAB9A (0.59) SMN1; SMN2MEN1KMT2AHPGDKDM4E
SCHEMBL7761958 0.84 MEN1 (0.56) SMN1; SMN2MEN1KMT2AHPGDKDM4E
SCHEMBL7113128 0.82 TAS1R3 (0.64) SMN1; SMN2MEN1KMT2AHPGDKDM4E
SCHEMBL10943491 0.82 HPGD (0.78) SMN1; SMN2MEN1KMT2AHPGDRECQL
SCHEMBL12173052 0.81 KMT2A (0.67) SMN1; SMN2MEN1KMT2AHPGDRECQL
SCHEMBL7763495 0.80 SMN1; SMN2 (0.49) SMN1; SMN2MEN1KMT2AHPGDRECQL
SCHEMBL7120573 0.79 TP53 (0.55) SMN1; SMN2HPGDKDM4EALDH1A1MAPT
SCHEMBL14452073 0.77 NPC1 (0.56) SMN1; SMN2MEN1KMT2AHPGDRECQL
SCHEMBL14095981 0.77 MAPT (0.64) SMN1; SMN2MEN1KMT2AHPGDRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030212074-A1 Phosphate transport inhibitors SMITHKLINE BEECHAM CORPORATION 2003-11-13 — — US claimed
US-20030212074-A1 Phosphate transport inhibitors SMITHKLINE BEECHAM CORPORATION 2003-11-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212074-A1 Phosphate transport inhibitors SLC34A2, SLC34A3, SLC34A1 SMN1; SMN2 4632/4885MEN1 2716/4885KMT2A 3005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback